Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03246919 · ClinicalTrials.gov registry record · Phase 4
Ideal Time of Oxytocin Infusion During Cesarean Section
A Phase 4 study, sponsored by Loyola University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
NCT03246919 is a Phase 4 study that was terminated before completion, run by Loyola University. The registered enrollment target is 68 participants.
The verdict
NCT03246919, a Phase 4 study, was terminated before completion, sponsored by Loyola University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
Study Summary
This study will evaluate if the timing of oxytocin administration in cesarean deliveries will affect the amount of maternal blood loss. Half of participants will receive oxytocin after delivery of the fetal anterior shoulder and the other half will receive oxytocin after delivery of the placenta. We hypothesize that administering oxytocin after delivery of the shoulder, will result in less overall maternal blood loss.
Interventions
- DRUG Placebo
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2020-02-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03246919
The ClinicalTrials.gov registry entry for NCT03246919 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03246919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03246919 about?
NCT03246919 is a clinical study titled "Ideal Time of Oxytocin Infusion During Cesarean Section". This study will evaluate if the timing of oxytocin administration in cesarean deliveries will affect the amount of maternal blood loss. Half of participants will receive oxytocin after delivery of the fetal anterior shoulder and the other half will receive oxytocin after delivery of the placenta. We...
What is the current status of trial NCT03246919?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2017-09-13. Estimated completion is 2020-02-24.
What interventions are being tested in trial NCT03246919?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03246919?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.